BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20930144)

  • 21. Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.
    Mallano T; Palumbo-Zerr K; Zerr P; Ramming A; Zeller B; Beyer C; Dees C; Huang J; Hai T; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Mar; 75(3):586-92. PubMed ID: 25589515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
    Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.
    Ferrand N; Gnanapragasam A; Dorothee G; Redeuilh G; Larsen AK; Sabbah M
    PLoS One; 2014; 9(2):e87878. PubMed ID: 24498388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
    Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
    Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.
    Yin X; Dewille JW; Hai T
    Oncogene; 2008 Apr; 27(15):2118-27. PubMed ID: 17952119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.
    Yoon CH; Kim MJ; Lee H; Kim RK; Lim EJ; Yoo KC; Lee GH; Cui YH; Oh YS; Gye MC; Lee YY; Park IC; An S; Hwang SG; Park MJ; Suh Y; Lee SJ
    J Biol Chem; 2012 Jun; 287(23):19516-27. PubMed ID: 22511756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of ATF3 interaction with Smad4 via TGF-β1 for matrix metalloproteinase 13 gene activation in human breast cancer cells.
    Rohini M; Arumugam B; Vairamani M; Selvamurugan N
    Int J Biol Macromol; 2019 Aug; 134():954-961. PubMed ID: 31082421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer.
    Gupta P; Srivastava SK
    Mol Oncol; 2014 Dec; 8(8):1532-47. PubMed ID: 24994678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells.
    Yadav P; Shankar BS
    Biomed Pharmacother; 2019 Mar; 111():119-130. PubMed ID: 30579251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing CD44+/CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis.
    Wang KH; Kao AP; Chang CC; Lee JN; Hou MF; Long CY; Chen HS; Tsai EM
    Mol Cancer; 2010 Nov; 9():288. PubMed ID: 21044318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SHON, a novel secreted protein, regulates epithelial-mesenchymal transition through transforming growth factor-β signaling in human breast cancer cells.
    Li L; Liu DX; Zhang N; Liang Q; Feng J; Yao M; Liu J; Li X; Zhang Y; Lu J; Huang B
    Int J Cancer; 2015 Mar; 136(6):1285-95. PubMed ID: 25082541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β1-stimulation of NFATC2 and ATF3 proteins and their interaction for matrix metalloproteinase 13 expression in human breast cancer cells.
    Rohini M; Vairamani M; Selvamurugan N
    Int J Biol Macromol; 2021 Dec; 192():1325-1330. PubMed ID: 34687766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44
    Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.